Friday 6 November 2026 Export TMDX’s income statement to Excel — free account

TransMedics Group, Inc.

TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.

Revenue: +41.2%
EPS: −31.0%
Free cash flow: −55.4%
Total debt: −89.3%

Quarter to September 2026, against a year earlier

85.47 16.49 +23.91%

Follow TMDX

Alert me

Market cap: $2.4B
P/E: 16.4×
Fwd P/E: 49.4×
Dividend yield: —
F-score: 7/9
Altman Z: 5.32
Beneish M: −1.32
Dividend safety: n/a

Overview

TransMedics Group, Inc. (TMDX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, TransMedics Group, Inc. (TMDX) trades at a P/B ratio of 4.3×. Over the past ten years it has ranged from 0.0× (June 2019) to 30.9× (June 2024); the current reading is higher than 11% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TMDX/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="TransMedics Group, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TMDX/metrics/pb-ratio">TransMedics Group, Inc. (TMDX) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	8.7×	(3.56%)
FY2024	9.1×	(50.21%)
FY2023	18.2×	102.05%
FY2022	9.0×	15.52%
FY2021	7.8×	64.81%
FY2020	4.7×	(4.24%)
FY2019	4.9×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/B ratio	Change
Sep 2026	5.3×	18.57%
Jun 2026	4.4×	(35.92%)
Mar 2026	6.9×	(20.84%)
Dec 2025	8.7×	(18.88%)
31 more quarters	Free account

Against its own ten years

Low 0.0× High 30.9×

Ten-year median 9.7×

Current reading's percentile 9

Company	P/B ratio
NEOG Neogen Corporation compare	1.2×
INSP Inspire Medical Systems, Inc. compare	2.3×
TMDX TransMedics Group, Inc.	4.3×
NVCR NovoCure Limited compare	4.5×
UFPT UFP Technologies, Inc. compare	5.0×
AXGN AxoGen, Inc. compare	5.4×
ALMR Alamar Biosciences, Inc. compare	6.2×
BFLY Butterfly Network, Inc. compare	8.8×
ESTA Establishment Labs Holdings Inc. compare	89.6×
Medical Devices industry median	2.5×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

TransMedics Group, Inc. (TMDX) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on TMDX

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on TMDX

Stockrow Weekly